Prescription prices
Moving
A 100 percent tariff on some patented imports is not the same thing as a lower copay.
Post this to X, with the sourceThe promise
Most-favored-nation style pressure on drugmakers. Import discipline. Lower prices at the pharmacy.
What happened
- April 2, 2026 proclamation: 100 percent duty on listed patented drug imports, with exemptions.
On April 2, 2026 the president issued a proclamation, Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients. Ballotpedia quotes it: a 100 percent duty on patented pharmaceuticals and ingredients listed in an annex, with a separate annex of products kept at a zero Section 232 tariff. A tariff is a tax on the importer. It can push production onshore over time. It can also raise the price of the imported drug. It is not, by itself, a cut in your copay.
The White House says price agreements were negotiated. This ledger does not have an independent national series for what insured patients paid in 2026, so it will not invent a percent drop. If the copay moved, the evidence is the pharmacy receipt and an audited price index, not the proclamation.
What is holding it up
Medicare’s drug-negotiation statute was already law before this term. Changing it takes another statute, and that is a 60-vote problem unless it fits inside reconciliation. A tariff proclamation can be amended by the next proclamation, which this White House does often. Pharmacy benefit managers and patent length sit in statutes, not in a speech.
Still ahead
- No independent copay index is cited here.
- Tariffs can be rewritten without Congress.
Dates
Apr 2, 2026 · Proclamation
Drug-import duties
100 percent on listed patented products. Zero-tariff annex for others. Quoted by Ballotpedia from the proclamation.
Watch the receipt. Until a public price series shows a drop, “we negotiated” is a claim, and the tariff is a tax.
Updated October 13, 2026.
Call your reps